CDSCO Flags 74 Drugs, Devices Samples as NSQ in December: Zerodol-SP, Defcort, Telmisartan, Amikacin Among Failed Products
Written By : Susmita Roy
Published On 2026-01-22 13:48 GMT | Update On 2026-01-22 13:49 GMT
Advertisement
New Delhi: As part of a nationwide quality surveillance drive, the Central Drugs Standard Control Organisation (CDSCO) has flagged 74 drugs, pharmaceutical formulations, medical devices, and allied healthcare products as Not of Standard Quality (NSQ) during routine testing conducted in December 2025.
The failures reported by central and regional drug testing laboratories across India, span critical therapeutic categories, including antibiotics, cardiovascular drugs, anti-diabetics, injectables, syrups, suspensions, APIs, excipients, medical devices, and even surgical bandages.
Advertisement
The NSQ list includes commonly prescribed medicines such as Dexamethasone Sodium Phosphate Injection IP 4 mg/ml. DEXOHIN manufactured by Hindustan Medicines, Amikacin Injection IP 100 mg manufactured by Agron Remedies, Telmisartan Tablets IP manufactured by BENNET Pharmaceuticals, Vildagliptin and Metformin Tablets IP manufactured by Unicure India, Clopidogrel & Aspirin Tablets IP manufactured by Theon Pharmaceuticals and others.
The list further includes widely used medicines such as Aceclofenac 100 mg, Serratiopeptidase 15 mg & Paracetamol 325 mg Tablets Zerodol-SP manufactured by Ipca Laboratories, Deflazacort Tablets 6 mg (Defcort 6) manufactured by Macleods Pharmaceuticals, Progesterone Sustained Release Tablets 300 mg (OPTOGEST 300) SR manufactured by Synokem Pharmaceuticals, Primaquine Phosphate Tablets IP 2.5 mg manufactured by Jackson Laboratories, and others.
The reasons for declaring the products Not of Standard Quality (NSQ) were wide-ranging and multi-factorial. These included assay failures, where the active pharmaceutical ingredient was found outside permissible limits; dissolution failures in solid oral dosage forms; sterility test failures in injectables and infusions; and the presence of particulate matter.
Drugs that fail to meet the quality standards or specifications are known as Not of Standard Quality (NSQ) drugs. The term ‘standards of quality’ is defined under Section 16 (1) (a) of the Drugs and Cosmetics Act, 1940, as ‘standards of quality’, meaning that the drug complies with the standards set out in the Second Schedule of the said Act.
NOT OF STANDARD QUALITY (NSQ) ALERT FOR THE MONTH OF DECEMBER 2025
| S.No | Name of Product | Batch No | Manufacturing Date | Expiry Date | Manufactured By | NSQ Result | Reporting Source | Reporting by Lab/State | Reporting Month & Year |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Diclofenac Gastro-resistant Tablets I.P. 50 mg | 25T19052 | Feb-2025 | Jan-2027 | Kras Pharmaceuticals Pvt. Ltd., C/15, Phase - II, Industrial Area, Fatwah -803201, Bihar | The sample does not conform to IP with respect to test for Dissolution in Buffer Stage. | CDSCO Labs | CDL, Kolkata | DEC-2025 |
| 2 | ITRAZIL-200 | HA237 | Feb-2025 | Jan-2027 | Trio Lifescience Private Ltd, 3008, G.I.D.C., Phase-IV, Vatva, Ahmedabad-382445. | The sample received does not conform to The manufacture's specification with respect to The test for pH. | CDSCO Labs | CDTL, Mumbai | DEC-2025 |
| 3 | Polymeg 200, | INTK038722 | Aug-2025 | Aug-2028 | Clariant IGL Specialty Chemicals Pvt. Ltd., (Formerly Known as IGL Green Chemicals Pvt. Ltd.) A-1, Industrial Area, Bazpur Road, Kashipur, Uttarakhand-244713 | The sample received does not conform to U.S.P. specification with respect to The content of diethylene glycol impurity, which is exceeding permissible limit | CDSCO Labs | CDTL-Hyderabad | DEC-2025 |
| 4 | Sorbitol Solution 70% IP (Non-Crystallizing) | KA/017 | Aug-2025 | Jul-2030 | Gujarat Ambuja Exports Limited Sy No 153/1,154-1/2/3,Madli Cross P.B Road (NH-4),Village Hulsoggi 581205P.O Manakatti,TQ Shiggoan Dist Haveri/Karnataka | The sample received does not conform to I.P. 2022 specification with respect to The content of ethylene glycol impurity, which is exceeding permissible limit | CDSCO Labs | CDTL-Hyderabad | DEC-2025 |
| 5 | Sorbitol Solution 70% IP (Non-Crystallizing) | KA/017 | Aug-2025 | Aug-2030 | Gujarat Ambuja Exports Limited Sy No 153/1,154-1/2/3,Madli Cross P.B Road (NH-4),Village Hulsoggi 581205P.O Manakatti,TQ Shiggoan Dist Haveri/Karnataka | The sample does not conform to I.P. 2022 specification with respect to the content of ethylene glycol impurity, which is exceeding permissible limit | CDSCO Labs | CDTL-Hyderabad | DEC-2025 |
| 6 | Ondansetron and Ranitidine HCI Injection Vomibac R Injection | 110525 | May-2025 | Apr-2027 | Pharma Chemico Laboratories Devghat, P.O., Saproon, Solan - 173211 (HP) | The sample received does not conform to manufacturer specification with respect to The test for pH only. | CDSCO Labs | CDTL-Hyderabad | DEC-2025 |
| 7 | Cefixime & Lactic Acid Bacillus Tablets Medisefix - 200 LB | DBT138A | Oct-2023 | Sep-2026 | Digital Vision 176, Mauza Ogli, Nahan Road, Kala-Amb, Distt. Sirmour (H.P.) - 173 030 | The sample does not conform to claim with respect to The Assay of Cefixim and Lactic Acid Bacillus. | CDSCO Labs | CDL, Kolkata | DEC-2025 |
| 8 | Hydroxyzine Oral Solution I.P. | HO1LF002 | Jun-2025 | May-2027 | Unicure India Ltd. Plot No. 46(B)/49B, Vill. Raipur, Bhagwanpur, Roorkee, Distt. Haridwar, Uttarakhand | The sample does not conform to claim as per IP 2022 in respect to The test of Related Substance | CDSCO Labs | CDL, Kolkata | DEC-2025 |
| 9 | Amikacin Sulphate Injection I.P. Mikabenz 500 | SVI-24070 | May-2024 | Apr-2026 | Sunvet Healthcare, Village Shambhuwala, Paonta Road, Distt. Sirmour (H.P.), 173001 | The sample does not conform to I.P. with respect to test for Particulate matter and is also not of standard quality for The reason stated under Description. | CDSCO Labs | CDL, Kolkata | DEC-2025 |
| 10 | Enteric Coated Rabeprazole Sodium & Domperidone Sustained release Capsules Rabizole - DSR | SPK 1386 | Nov-2024 | Oct-2026 | Spanker Biotech Ltd. Vill. Makhanu Majra, Bhud Road, Baddi, Tehsil Nalagarh, Distt. Solan - 173205 (H.P.) | The sample does not conform to Manufacturers Specification with respect to The Test of Dissolution of Rabeprazole Sodium and Assay of Rabeprazole Sodium. | CDSCO Labs | CDL, Kolkata | DEC-2025 |
| 11 | Phenylephrine Hydrochloride, Chlorpheniramine Maleate Qr-Cold Syrup | WDLB012 | Jun-2025 | May-2027 | Westerlin Drugs Pvt. Ltd. Industrial Area Fatuha (Patna) - 803201 | The sample does not conform to I.P. with respect to The Assay of Phenylephrine Hydrochloride. | CDSCO Labs | CDL, Kolkata | DEC-2025 |
| 12 | Rabeprazole Sodium and Domperidone Sustained Release Capsules RABILITE-DSR | B20824002 | Feb-2024 | Jan-2026 | Torque Pharmaceuticals Pvt. Ltd 13B-14, EPIP-I, Jharmajri, H.P.- 173205 | The sample does not conform to Manufacturers Specification with respect to The test of Dissolution of Rabeprazole Sodium (Acid Resistance in 0.1M HCl). | CDSCO Labs | CDL, Kolkata | DEC-2025 |
| 13 | Dexamethasone Sodium Phosphate Injection IP 4 mg/ml. DEXOHIN | 69 | Jun-2025 | May-2027 | Hindustan Medicines Pvt. Ltd. Barauni-851112 Bihar | The sample does not conform to IP with respect to test for Particulate matter and is also not of standard quality for The reason stated under Description. | CDSCO Labs | CDL, Kolkata | DEC-2025 |
| 14 | Amikacin Injection IP 100 mg | LI25292 | Sep-2025 | Aug-2027 | Agron Remedies Pvt. Ltd. Sarverkhera, Moradabad Road, Kashipur-244713, (Uttarakhand). | The sample does not conform to I.P. with respect to test for Particulate matter and is also not of standard quality for The reason stated under Description. | CDSCO Labs | CDL, Kolkata | DEC-2025 |
| 15 | Albendazole Oral Suspension IP ALBEND | LBS-006/25 | Oct-2025 | Sep-2028 | Drakt International, Diamond Harbour Road Joka Kolkata 700104 , West Bengal | The sample does not conform to I.P. with respect to The Assay of Albendazole. | CDSCO Labs | CDL, Kolkata | DEC-2025 |
| 16 | Rabeprazole Sodium Injection IP | MD24G42 | Jul-2024 | Jun-2026 | Martin &Brown Bio-Sciences Pvt. Ltd. K.No 918/419, Malkumajra, Nalagarh Road, Baddi, Distt. Solan (H.P.) 173205 | The sample does not conform to I.P. with respect to The tests of Description, Clarity of Solution, Particulate Matter, pH, Related Substances and Assay of Rabeprazole Sodium. | CDSCO Labs | CDL, Kolkata | DEC-2025 |
| 17 | Ambroxol Hydrochloride, Guaiphenesin and Levosalbutamol Syrup Corun-LA Junior Syrup | A20497B | Mar-2025 | Feb-2027 | Aspen Lifesciences Plot No. 57, Nagkalan Industrial Area, Majitha Road, Amritsar-143601 Punjab | The sample does not conform to claim as per Manufacturer's Specification with respect to Assay of Ambroxol Hydrochloride. | CDSCO Labs | CDL, Kolkata | DEC-2025 |
| 18 | Omeprazole Capsules 40 mg | JDC-1452 | Oct-2024 | Sep-2026 | Jpee Drugs Plot No-53, Sector 6-A, SIDCUL, Haridwar (Uttarakhand) | The sample does not conform to claim as per I.P. 2022 in respect to The Test of Dissolution (Acid Stage), Dissolution (Buffer Stage) | CDSCO Labs | CDL, Kolkata | DEC-2025 |
| 19 | Telmisartan Tablets IP | 24305 | Oct-2024 | Sep-2026 | BENNET Pharmaceuticals Ltd. VILL-Chanal Majra Near-Manpura, Baddi Distt- Solan H.P.-173205. | The sample is not of standard quality for The reason stated under Description. | CDSCO Labs | CDL, Kolkata | DEC-2025 |
| 20 | Oral Rehydration Salts IP | OE50244 | Sep-2025 | Feb-2027 | Caplet India Pvt.Ltd. Rekjuani,Kolkata-700135 | The sample does not conform to I.P. with respect to Uniformity of weight, Seal test and also for The reason stated under Description. | CDSCO Labs | CDL, Kolkata | DEC-2025 |
| 21 | Lorazepam Injection IP 2 mg/ml, 2 ml WELOR | WALV24001A | Oct-2024 | Mar-2026 | Welcure Remedies Nahan Road, Vill Moginand, Distt. Sirmour-173030(HP) | The sample does not conform to I.P. with respect to test for Particulate matter, Assay and is also not of standard quality for The reason stated under Description. | CDSCO Labs | CDL, Kolkata | DEC-2025 |
| 22 | Ambroxol Hydrochloride I.P-15.0mg Terbutaline Sulphate I.P-1.25mg Guaiphenesin I.P 50.0mg Menthol I.P -2.5mg GBS JUNIOR | 25L06 | Feb-2025 | Jan-2028 | Oro Pharmaceuticals Pvt Ltd, New Industrial Estate ,Jagatpur-754021,Cuttack Odisha | The sample does not conform to claim with respect to Assay of Menthol. | CDSCO Labs | CDL, Kolkata | DEC-2025 |
| 23 | Bromhexine Hydrochloride,Terbutaline Sulphate,Guaiphenesin & Menthol Syrup Respifresh-TR | R12GL2426 | Dec-2024 | Nov-2026 | Rednex Pharmaceuticals Limited Survey No : 586 & 231, NR. SKF Bearing, Bavla Bagodara, N.H.-8A, Kerala, Tal. Bavla, Dist-Ahmedabad-382220 | The sample does not conform to claim as per Schedule V, Drugs & Cosmetics Act in respect to The Assay of Menthol. | CDSCO Labs | CDL, Kolkata | DEC-2025 |
| 24 | Rabeprazole Sodium (EC) & Domperidone (SR) Capsules RABIVO-DSR | CG25-0039P | Feb-2025 | Jan-2027 | Athens Life Sciences Mauza Rampur Jattan, Nahan Road, Kala Amb, Distt. Sirmour, H.P.-173030 | The sample does not conform to claim with respect to The Assay of Rabeprazole Sodium. | CDSCO Labs | CDL, Kolkata | DEC-2025 |
| 25 | Progesterone Sustained Release Tablets 300 mg OPTOGEST 300 SR | T2B15001 | Feb-2025 | Jan-2027 | Synokem Pharmaceuticals Ltd. No.56-57, Sector 6A, IIE,SIDCUL, Ranipur, Distt. Haridwar-249403 (Uttarakhand) | The sample does not conform to claim as per Manufacturer Specification with respect to test for Dissolution. | CDSCO Labs | CDL, Kolkata | DEC-2025 |
| 26 | Diclofenac Sodium, Paracetamol & Chlorzoxazone Tablets Diclotrum-MR | SGT-231863 | Jan-2024 | Dec-2025 | Spectrum Formulation Pvt. Ltd. Khasra No.12,Makhanpur,Bhagwanpur,Roorkee, Hridwar (U.K.) 247661 | The sample does not conform to claim with respect to Description. | CDSCO Labs | CDL, Kolkata | DEC-2025 |
| 27 | Paracetamol Tablets IP 500 mg | PCT-2445 | Oct-2024 | Mar-2027 | Suprex Laboratories, 11/C, Industrial Area, Maxi Road, Ujjain (MP) | The sample does not comply as per I.P. 2022 with respect to The test for Dissolution of Paracetamol. | CDSCO Labs | RDTL, Guwahati | DEC-2025 |
| 28 | Primaquine Phosphate Tablets IP 2.5 mg | T-1909 | Jun-2024 | May-2026 | Jackson Laboratories Pvt. Ltd. Majitha Road, Bye Pass, Amritsar - 143001 Punjab | The sample does not conform to claim as per I.P. 2022 with respect to The test for Assay and Dissolution of Primaquine. | CDSCO Labs | RDTL, Guwahati | DEC-2025 |
| 29 | Paracetamol Tablets IP 650 mg Arvimol 650 Tablets | 24I-T1956E | Dec-2024 | Nov-2026 | Orison Pharma International Khari, Mauza Ogli, Kala Amb, Distt. Sirmour - 173030 (H.P.) | The sample is not of standard quality for The reason stated under Description of The tablets. | CDSCO Labs | RDTL, Guwahati | DEC-2025 |
| 30 | Dexamethasone Tablets BP 8 mg. Dexarid-8 | RT230508 | Jul-2023 | Jun-2026 | Ridley Life Science Pvt. Ltd D-1651, DSIDC, Indl. Complex, Narela, Delhi- 110040 | The sample does not conform to claim as per B.P. 2025 with respect to The test for Assay of Dexamethasone. | CDSCO Labs | RDTL, Guwahati | DEC-2025 |
| 31 | Calcium & Vitamin D3 Tablets IP (500 mg/250IU) | CDA-583 | Mar-2025 | Feb-2027 | Healers Lab Unit-II, Plot No. 33, HPSIDC Extn., Baddi, Dist.-Solan, H.P. | The sample does not comply as per I.P. 2022 with respect to The test for Dissolution of Calcium. | CDSCO Labs | RDTL, Guwahati | DEC-2025 |
| 32 | Telmisartan Tablets IP 40mg Savtel 40 Tablets | PT- 40584 | Feb-2024 | Jan-2026 | Pharmaroots Healthcare Khasra No. 411, Village Tipra, P.O. Barotiwala, Tehsil Baddi, Distt. Solan, H.P. | The sample does not comply as per I.P. 2022 with respect to The test for Dissolution of Telmisartan. | CDSCO Labs | RDTL, Guwahati | DEC-2025 |
| 33 | Amlodipine Tablets I.P. 2.5 mg | 424-1522 | Aug-2024 | Jul-2026 | Zee Laboratories 47, Industrial Area, Paonta Sahib-173025 | The sample is not of standard quality for The reason stated under Description of The tablets. | CDSCO Labs | RDTL, Guwahati | DEC-2025 |
| 34 | Aceclofenac 100 mg, Serratiopeptidase 15 mg & Paracetamol 325 mg Tablets Zerodol-SP | FND072001BH | Jan-2025 | Jun-2027 | Ipca Laboratories Ltd. 393/394, Melli Jorethang Road, Gom Block, Bharikhola, South District, Sikkim 737 121 | The sample does not conform to claim as per Patent and Proprietary in respect to The Assay of Paracetamol, Aceclofenac, Serratiopeptidase | CDSCO Labs | RDTL, Chandigarh | DEC-2025 |
| 35 | Cyproheptadine, Tricholine and Sorbitol oral solution Cypliv | L25078 | Aug-2025 | Jul-2027 | Wamika Pharmaceuticals Private Limited, #318, HSIIDC, Industrial Growth Centre, Sector-2, Phase-I, Saha-133104, Distt. Ambala (Haryana) | The sample does not conform to claim as per Patent and Proprietary in respect to The Assay of Sorbitol (70%). | CDSCO Labs | RDTL, Chandigarh | DEC-2025 |
| 36 | Albendazole Tablet IP | PGT24347 | Jun-2024 | May-2027 | Affy Parenterals Vill. Gullarwala, P.O. Baddi, Distt. Solan- 173 205 (HP) | The sample does not conform to claim as per IP 2022 in respect to The Test of Dissolution | CDSCO Labs | RDTL, Chandigarh | DEC-2025 |
| 37 | LEVTARY - 500 | AA250585A | Jul-2025 | Jun-2027 | Gufic Biosciences Limited N.H.No. 08 Kabilpore, Navsari Gujarat 396424 (India) | The sample does not conform to claim as per Patent and Proprietary in respect to The Test of Free drug | CDSCO Labs | RDTL, Chandigarh | DEC-2025 |
| 38 | Levetiracetam Tablets IP 500 mg | LTH2505 | Sep-2025 | Aug-2027 | Applied Communication & Controls, Khasra No.122, Selaqui Industrial Area, Dehradun, Uttarakhand. | The sample does not conform to claim as per IP 2022 in respect to The Test of Dissolution. | CDSCO Labs | RDTL, Chandigarh | DEC-2025 |
| 39 | Ambroxol Hydrochloride, Terbutaline Sulphate, Guaiphenesin & Menthol Syrup Wamicof-AX Expectorant | L25082 | Sep-2025 | Aug-2027 | Wamika Pharmaceuticals Private Limited, #318, HSIIDC, Industrial Growth Centre, Sector-2, Phase-I, Saha-133104, Distt. Ambala (Haryana) | The sample does not conform to claim as per Patent and Proprietary in respect to The Assay of Terbutaline Sulphate | CDSCO Labs | RDTL, Chandigarh | DEC-2025 |
| 40 | Piperacillin and Tazobactam Injection I.P. 4.5 gm | 325-1088 | Aug-2025 | Jul-2027 | Zee Laboratories Ltd. Behind 47, Industrial Area, Paonta Sahib-173025 | The sample does not conform to claim as per IP 2022 in respect to The Test of Particulate matter | CDSCO Labs | RDTL, Chandigarh | DEC-2025 |
| 41 | Piperacillin and Tazobactam Injection I.P. 4.5 gm | 325-1090 | Aug-2025 | Jul-2027 | Zee Laboratories Ltd.Behind 47, Industrial Area, Paonta Sahib-173025 | The sample does not conform to claim as per IP 2022 in respect to The Test of Particulate matter. | CDSCO Labs | RDTL, Chandigarh | DEC-2025 |
| 42 | Deflazacort Tablets 6 mg Defcort 6 | 13240334A | Jun-2024 | May-2027 | Macleods Pharmaceuticals Ltd. 367/7, Kabra Industrial Estate, Kachigam, Daman 396 210 (U.T.) | The sample does not conform to claim as per Patent and Proprietary in respect to The Test of Identification and Assay of Deflazacort | CDSCO Labs | RDTL, Chandigarh | DEC-2025 |
| 43 | Levosalbutamol, Ambroxol Hydrochloride & Guaiphenesin Syrup STUQOF-LS | TS-538 | Jul-2025 | Jun-2027 | Trimedix Pharma (P) Ltd. C-40, I.A. Phase-III, Mohali-160055 Punjab | The sample does not conform to claim as per Patent and Proprietary in respect to The Assay of Levosalbutamol Sulphate calculated as Levosalbutamol | CDSCO Labs | RDTL, Chandigarh | DEC-2025 |
| 44 | Ambroxol,Terbutaline,Guaiphenesin and Menthol syrup AMBROLET-LS | OS-12095 | Sep-2025 | Aug-2027 | Omnison Pharma Pvt. Ltd. G-456,G-457,UPSIDC,Phase-II, M.G. Road ,Dist.Hapur (U.P.), India. | The sample does not conform to claim as per Patent and Proprietary in respect to The Test of Total yeast and mould count. | CDSCO Labs | RDTL, Chandigarh | DEC-2025 |
| 45 | Aceclofenac 100 mg, Serratiopeptidase 15 mg & Paracetamol 325 mg Tablets ZERODOL-SP TABLETS | FND0725001BH | Jan-2025 | Jun-2027 | Ipca Laboratories Ltd. 393/394, Melli Jorethang Road, Gom Block, Bharikhola, South District, Sikkim 737 121 | The sample does not conform to claim as per Patent and Proprietary in respect to The Assay of Aceclofenac, Paracetamol, Serratiopeptidase | CDSCO Labs | RDTL, Chandigarh | DEC-2025 |
| 46 | Levosalbutamol, Ambroxol Hydrochloride & Guaiphenesin Syrup AMBROX-LG | TS-249 | Apr-2025 | Mar-2027 | Trimedix Pharma (P) Ltd. C-40, I.A. Phase-III, Mohali-160055 Punjab | The sample does not conform to claim as per Patent and Proprietary in respect to The Assay of Levosalbutamol Sulphate calculated as Levosalbutamol | CDSCO Labs | RDTL, Chandigarh | DEC-2025 |
| 47 | Ranitidine Oral Solution IP ZALTAC Syrup | MDL-C490 | Aug-2025 | Jul-2027 | Marvellon Pharmaceuticals Pvt. Ltd. Kh. No. 114, Vill. Damowala, P.O. Barotiwala, Baddi, Distt. Solan (H.P.) 174103 | The sample does not conform to claim as per IP 2022 in respect to The test pH and Assay of Ranitidine Hydrochloride calculated as Ranitidine. | CDSCO Labs | RDTL, Chandigarh | DEC-2025 |
| 48 | Ondansetron Tablets IP Anset Tablets | RBMT-921 | Sep-2025 | Aug-2028 | Ronald Pharmaceuticals (P) Ltd. B.No. 740-A, At. Manjusar, Tal.Savli, Dist. Vadodara-391775 Gujarat | The sample does not conform to I.P. 2022 with respect to The test for Related substances. | CDSCO Labs | CDTL, Mumbai | DEC-2025 |
| 49 | Prednisolone Sodium Phosphate Drops Reslone (Drops 10ml) | L-250705 | Jul-2025 | Jun-2027 | Dr. Pal'S Pharmaceuticals 10B-1, Industrial Park-2, Salempur, Mahdood Haridwar (Uttarakhand) India. | The sample received does not conform with respect to The test for weight per ml. | CDSCO Labs | CDTL, Mumbai | DEC-2025 |
| 50 | Ibuprofen and Paracetamol Suspension SNEFLAM DS SUSPENSION, 60 ml | L25J001 | Oct-2025 | Sep-2027 | Snehal Pharma & Surgicals Pvt. Ltd. B-1/11, B-2/1, M.I.D.C., Butibori, Nagpur-441122, Maharashtra (India) | The sample does not conform to claim with respect to The test for Microbial contamination (Test of Total Aerobic Viable Count) | CDSCO Labs | CDTL, Mumbai | DEC-2025 |
| 51 | Tigecycline Injection IP 50 mg Tigelite Injection 50mg) | LAA139 | Mar-2025 | Feb-2027 | Lyka Labs Ltd. Plot No. 4801/B & 4802/A, GIDC Industrial Estate, Ankleshwar - 393 002, Gujarat, India. | The sample does not conform to I.P. 2022 with respect to test for Related substances . | CDSCO Labs | CDTL, Mumbai | DEC-2025 |
| 52 | Itraconazole Capsules BP 200 mg | R08GC2506A | Aug-2025 | Jul-2027 | Rednex Pharmaceuticals Ltd. Survey No : 586 & 231, NR. SKF Bearing, Bavla Bagodara, N.H.-8A, Kerala, Tal. Bavla, Dist-Ahmedabad-382220 | The sample received does not conform to I.P. 2022 with respect to The test for Dissolution. | CDSCO Labs | CDTL, Mumbai | DEC-2025 |
| 53 | Vildagliptin and Metformin Tablets IP | VMHT1315 | May-2025 | Apr-2027 | Unicure India Ltd C-21, 22 & 23, Sector-3, Noida-201301, Distt. Gautam Budh Nagar (U.P) Uttar Pradesh | The sample received does not conform to I.P. 2022 with respect to Assay and Dissolution. | CDSCO Labs | CDTL, Mumbai | DEC-2025 |
| 54 | Luliconazole Lotion IP 1% W/V LUZORAN Lotion 30ml | R09GE2518B | Sep-2025 | Aug-2027 | Rednex Pharmaceuticals Limited Survey No : 586 & 231, NR. SKF Bearing, Bavla Bagodara, N.H.-8A, Kerala, Tal. Bavla, Dist-Ahmedabad-382220 | The sample received does not conform to I.P. 2022 with respect to The test for Related substance. | CDSCO Labs | CDTL, Mumbai | DEC-2025 |
| 55 | Chlorpheniramine Maleate & Phenylephrine Hcl Syrup I.P. Ezicold Syrup 60ml | L3126 | Sep-2025 | Aug-2027 | Camper Healthcare Plot No. C-01, Ganpat Vidyanagar, Kherva-384012, Gujarat | The sample received does not conform to I.P. 2022 with respect to The test of Assay of Phenylephrine Hydrochloride. | CDSCO Labs | CDTL, Mumbai | DEC-2025 |
| 56 | Glycerin IP | 3F/RG/24/0054 | Nov-2024 | Oct-2029 | 3F Industries Ltd. 1604, EPURU 1 (B), Pantapalem, Nellore - 524323, A.P. India Andhra Pradesh | The sample received does not conform to I.P. 2022 with respect to The test for Aldehydes. | CDSCO Labs | CDTL, Mumbai | DEC-2025 |
| 57 | Menadione Sodium Bisulphite Injection IP Kaytin MB 1ml | MA25D33 | Apr-2025 | Mar-2027 | Martin & Brown Bio-Sciences Pvt. Ltd. K.No 918/419, Malkumajra, Nalagarh Road, Baddi, Distt. Solan (H.P.) 173205 | The sample received does not conform to The I.P. with respect to The test for Assay of Menadione Sodium Bisulphite | CDSCO Labs | CDTL, Mumbai | DEC-2025 |
| 58 | Drotaverine HCl Suspension PED-DS suspension 60ml | L-250901 | Sep-2025 | Aug-2030 | Dr. Pal's Pharmaceuticals 10B-1, Industrial Park-2, Salempur, Mahdood Haridwar (Uttarakhand) India. | The sample does not conform to claim with respect to The test for Microbial contamination (Total Aerobic Viable Count and Total Fungal Count). | CDSCO Labs | CDTL, Mumbai | DEC-2025 |
| 59 | Neosorb 70/70B-Sirop De Sorbitol (Sorbitol Liquid, Crystallising USP/NF) | 599646 | Mar-2023 | Mar-2028 | Roquette Freres, France | The sample received does not conform to as per IP in respect to The test for angle of Rotation only. | CDSCO Labs | CDTL, Chennai | DEC-2025 |
| 60 | Paracetamol Tablets IP 650mg | PCT25057 | Apr-2025 | Mar-2027 | Vivek Pharmachem (India) Ltd. NH-8, Chimanpura, Amer, Jaipur-303 102 | The sample received does not conform to as per IP in respect to The test for Dissolution. | CDSCO Labs | CDTL, Chennai | DEC-2025 |
| 61 | Sorbitol Solution 70% IP Non Crystallizing | 2526010 | May-2025 | Apr-2030 | Gujarat Ambuja Exports Ltd. Plot No. A 04, Industrial Estate MIDC Area Kadki Chalisgoan Dist. Jalgoan 424101 Maharashtra | The sample does not conform to as Per IP in respect to The test for angle of Rotation. | CDSCO Labs | CDTL, Chennai | DEC-2025 |
| 62 | Clopidogrel & Aspirin Tablets IP | GT250518 | Mar-2025 | Feb-2027 | Theon Pharmaceuticals Ltd. Vill. Saini Majra, Tehsil Nalagarh, Distt. Solan (H.P.) 174 101. | The sample Received Does Not Conform To I.P. 2022 Specification With Respect To The Description And Test For Free Salicylic Acid Only. | CDSCO Labs | CDTL-Hyderabad | DEC-2025 |
| 63 | Clopidogrel & Aspirin Tablets IP | GT250519 | Mar-2025 | Feb-2027 | Theon Pharmaceuticals Ltd. Vill. Saini Majra, Tehsil Nalagarh, Distt. Solan (H.P.) 174 101. | The sample Received Does Not Conform To I.P. 2022 Specification With Respect To The Description And Test For Free Salicylic Acid Only. | CDSCO Labs | CDTL-Hyderabad | DEC-2025 |
| 64 | Levetiracetam Tablets IP 500 mg Epivell-500 Tablets | GT5F136 | Jun-2025 | May-2027 | Ritual Drugs Pvt. Ltd. (A WHO-GMP Certified Company) Plot No. 271-272, Phase-I, HSIIDC, Barhi Industrial Area, Sonepat (HR)-131101 Haryana | The sample received does not conform to I.P. 2022 specification with respect to The test for Dissolution only. | CDSCO Labs | CDTL-Hyderabad | DEC-2025 |
| 65 | Poly Ethylene Glycol - 200, | 43029642 | Feb-2025 | Jan-2027 | Saudi Basic Industries Corporation (SABIC), P.O Box 5101, Riyadh 11422, Kingdom Of Saudi Arabia. | The sample received does not conform to U.S.P. specification with respect to The content of ethylene glycol and diethylene glycol impurities, which are exceeding permissible limit | CDSCO Labs | CDTL-Hyderabad | DEC-2025 |
| 66 | Sorbitol Solution 70% IP (Non-Crystallizing) | KA/018 | Sep-2025 | Aug-2030 | Gujarat Ambuja Exports Limited Sy No 153/1,154-1/2/3,Madli Cross P.B Road (NH-4),Village Hulsoggi 581205P.O Manakatti,TQ Shiggoan Dist Haveri/Karnataka | The sample received does not conform to I.P. 2022 specification with respect to The content of ethylene glycol impurity, which is exceeding permissible limit | CDSCO Labs | CDTL-Hyderabad | DEC-2025 |
| 67 | Dextromethorphan Hydrobromide, Ambroxol Hydrochloride, Chlorpheniramine Maleate & Phenylephrine Hydrochloride Syrup Tusty Total | OLM24120 | Dec-2024 | Aug-2030 | Medishri Healthcare Pvt. Ltd. Khasra No.-27, Mandawar, Bhagwanpur, Roorkee, Distt. Haridwar (U.K.) Uttarakhand | The sample received does not conform to manufacturer specification with respect to The test for Assay of ambroxol hydrochloride content only. | CDSCO Labs | CDTL-Hyderabad | DEC-2025 |
| 68 | Paracetamol, Phenylephrine Hydrochloride & Chlorpheniramine Maleate Drops SINUS DROPS | 876/26 | Apr-2025 | Mar-2027 | Livin Formulations Survey No: 807 IDA Medchal Medchal-Malkajgiri District, Telangana, India. | The sample received does not conform to manufacturer specification with respect to The test for pH only. | CDSCO Labs | CDTL-Hyderabad | DEC-2025 |
| 69 | Olmesartan Medoxomil Tablets IP 40 mg OLMESON-40 | T-6585 | Jul-2025 | Jul-2027 | Jackson Laboratories Pvt.Ltd 22-24, Majitha Road, Bye Pass, Amritsar-143 001(India) Punjab | The sample received does not conform to I.P. 2022, I.P. addendum 2024 specification with respect to The test for Dissolution only. | CDSCO Labs | CDTL-Hyderabad | DEC-2025 |
| 70 | Metoprolol Succinate Prolonged Release Tablets IP Metloc ER50 | MER3 294D | Nov-2024 | Oct-2026 | Pulse Pharmaceuticals Pvt. Ltd. Khasra No. 400, 407, 409, Karondi, Roorkee, Uttarakhand-247 667 | The sample is not of standard quality for The reasons stated under Description | CDSCO Labs | CDTL -Indore | DEC-2025 |
| 71 | RYLES TUBE 12-FG (STERILE) | BRT-002 | Jul-2024 | Jun-2026 | Bhagwati Medicare Devices, 8, Maruti Industrial Estate, Nr. Sindhvai Mata Temple, C.T.M.- Ramol Road, Amraiwadi, Ahmedabad- 380026. Gujarat (India) | The sample does not conform to claim as per Patent and Proprietary in respect to The Test of Sterility | CDSCO Labs | RDTL, Chandigarh | DEC-2025 |
| 72 | Cotton Bandage | 940 | May-2025 | Apr-2027 | Sapna Bunkar Hath Kargha Sahkari Samiti Ltd., B-12(D), Malviya Industrial Area, Jaipur | The sample does not conform in respect to The Test of Threads per dm, Weight In Gm/sq.m, Foreign Matter, Fluorescence. | CDSCO Labs | CDL, Kolkata | DEC-2025 |
| 73 | Cotton Bandage | 937 | May-2025 | Apr-2027 | Sapna Bunkar Hath Kargha Sahkari Samiti Ltd., B-12(D), Malviya Industrial Area, Jaipur | The sample does not conform to The test of weight in Gm/sq.m, threads per dm, Fluorescence, Foreign Matter | CDSCO Labs | CDL, Kolkata | DEC-2025 |
| 74 | X-Plus Gold | VBX-044 | Jun-2025 | May-2028 | Vaidban Ayurved Bhawan Vill. Fadauli, P.O. Mohra, Distt. Ambala, Haryana -133004, India | The sample does not conform to claim as per Patent and Proprietary in respect to The Test of Tadalafil | CDSCO Labs | RDTL, Chandigarh | DEC-2025 |
Tags:
Susmita Roy, B pharm, M pharm Pharmacology, graduated from Gurunanak Institute of Pharmaceutical Science and Technology with a bachelor's degree in Pharmacy. She is currently working as an assistant professor at Haldia Institute of Pharmacy in West Bengal. She has been part of Medical Dialogues since March 2021.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.